The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD205-Shuttle study: A first-in-human trial of MEN1309/OBT076 an ADC targeting CD205 in solid tumor and NHL.
 
Elena Garralda
Consulting or Advisory Role - Roche
 
Josep Tabernero
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Genentech/Roche; Lilly; Merck Serono; MSD; Novartis; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Victor Moreno Garcia
No Relationships to Disclose
 
Maria José De Miguel
No Relationships to Disclose
 
Elizabeth Ruth Plummer
Honoraria - Bristol-Myers Squibb; Pfizer (I); Roche/Genentech
Consulting or Advisory Role - Astex Pharmaceuticals; Bayer; Clovis Oncology; Modulatex; MSD Oncology; Novartis; Octimet; Pierre Fabre; Roche/Genentech; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology
 
Guy Heinrich Maria Jerusalem
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Michele Spina
Honoraria - CTI; Gilead Sciences; Janssen-Cilag; Menarini; Mundipharma; Roche; Sandoz; SERVIER; Takeda; Teva
Consulting or Advisory Role - CTI; Gilead Sciences; Janssen-Cilag; Menarini; Mundipharma; Sandoz; SERVIER; Teva
Research Funding - Menarini
 
Christian Rohlff
Employment - Oxford BioTherapeutics
Leadership - Oxford BioTherapeutics
Stock and Other Ownership Interests - Oxford BioTherapeutics
Patents, Royalties, Other Intellectual Property - Oxford BioTherapeutics (Inst)
Travel, Accommodations, Expenses - Oxford BioTherapeutics
 
Abrahim Fandi
No Relationships to Disclose
 
Serena Buontempo
Employment - Menarini
 
Mariagiuseppa Matera
Employment - Menarini
 
Mario Cioce
Employment - Menarini
 
D'Angiolella Paola
Employment - Menarini
 
Monica Binaschi
No Relationships to Disclose
 
Giuseppe Merlino
No Relationships to Disclose
 
Paolo Mazzei
Employment - Menarini
Leadership - Menarini
 
Cristina Rossi
Employment - Menarini
 
Giulia Tonini
Employment - Menarini
 
Cecilia Simonelli
Employment - Menarini
Leadership - Menarini
 
Andrea Ugo Enrico Pellacani
Employment - Menarini
Leadership - Menarini
Stock and Other Ownership Interests - Amgen; Amgen (I)
Travel, Accommodations, Expenses - Menarini